The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to the institute’s ...

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

I think [this technology] will be among the most important things.' Similar experimental mRNA cancer vaccines have been in development since the technology was advanced during the Covid pandemic.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the Markey Cancer Center ...